Our Products

Engineering Sustainable Medical Devices and Preventive Digital Health Tools.

Every BEDEV product starts with a problem the industry has underprioritized and results in a device designed to improve clinical outcomes.

Pre-clinical Testing

ParaHealth Device

A Reusable Catheter Stabilization System

Peripheral intravenous catheters are used in the majority of hospital admissions worldwide. Current fixation relies on gauze or adhesive, the same approach used across every hospital, in every country. Published studies report failure rates between 35% and 50%, resulting in repeated procedures, infection risk, and increased cost. According to NIH studies, a third of total hospital PIVC expenditure goes toward materials from failed insertions. ParaHealth was designed to change that.

The ParaHealth Device is a reusable, modular catheter stabilization system engineered to reduce PIVC failure rates and improve catheter security. Adaptable to any catheter size, needle, or body part, it is designed for sterilization and reuse under standard hospital protocols, with individual components replaceable if damaged or worn. The result is improved catheter stability, reduced staff workload, and lower material waste. The device is being developed for CE Mark certification under EU MDR and FDA clearance pathways.

ParaHealth Insights

1 in 3

PIVC failure rate globally (NIH studies)

38 -46%

Estimated reduction in failure rates with ParaHealth

1 /3

Of total PIVC expenditure spent on failed insertions and associated waste

0 B

Catheters used globally per year

The scale of the problem ParaHealth is designed to address.

In Development

ADID | Assisted Detection for Immunologic Disease

An AI-Powered Allergy Prediction App

Allergic disease is the fourth leading cause of chronic illness worldwide. By 2050, an estimated 4 billion people will be affected.

ADID is a new digital health solution designed to help people anticipate and better manage their allergy symptoms. By combining environmental awareness with personal insights, ADID offers timely alerts about periods of higher sensitivity and helps users track how they feel over time. The result is a more proactive, informed, and personalized approach to allergy management — all from a simple, intuitive mobile app.

ADID Insights

What the data says about allergic disease worldwide.

Our Process

1 B

People projected to have allergies by 2050

1 th

Leading cause of chronic disease worldwide

0 B

Annual economic impact of allergies in Europe

7 to 10 days

Advance allergen prediction window

Where We Are Going Next

BEDEV is currently in active pre-clinical preparation for the ParaHealth Device, advancing across four parallel workstreams toward clinical validation in 2027.

To protect our intellectual property during pre-clinical development, detailed device specifications and imagery are not publicly displayed. A patent application for the ParaHealth Device has been submitted.
Full technical documentation is available to qualified partners under appropriate confidentiality agreements.

Start a Conversation

Whether you are a healthcare professional, a potential partner, a researcher, or an investor, we welcome conversations and partnerships that move healthcare forward.